Melanoma & Skin Cancer

A biomarker test for DNA methylation identified 22 gene sites able to differentiate between melanoma and nonmelanoma lesions

Bristol-Myers Squibb plans to start rolling out its newly approved melanoma drug ipilimumab (Yervoy) in the next several weeks

The FDA has approved the novel drug ipilimumab for the treatment of patients with metastatic melanoma

Cancer researchers and patient advocates are hailing the FDA's approval of Yervoy (ipilimumab)

James P. Allison has never hesitated to buck the system

Andrew L. Pecora, M.D., F.A.C.P., C.P.E. Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center, on his personal involvement in research.

Useful Online Resources and Clinical Trials for Melanoma

The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care

Various immunotherapeutic strategies to treat advanced melanoma have been under investigation for more than a decade

The Emperor of All Maladies bills itself as a "biography of cancer," and while author Siddhartha Mukherjee cannot tell us precisely when cancer opened its eyes in this world...

An article in Oncogene further explains how ultraviolet (UV) radiation helps transform skin cells into basal cell carcinoma.

The John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey, one of the largest cancer centers in the United States

Hospitals, pharmacists, and physicians across the United States are reporting shortages of critical anticancer drugs, including carboplatin, cisplatin, dacarbazine, fludarabine, and cytarabine.

In a phase III randomized trial, overall survival (OS) was more than 34% longer for patients with advanced melanoma who received the novel agent ipilimumab

A collection of statistics and facts on skin cancer and melanoma

Clinical investigations of tremelimumab in melanoma were the focus of several presentations at ASCO.

University of Pittsburgh scientists ecently discovered a virus that they have determined is the cause of Merkel cell carcinoma.